Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters

15 Jun 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35705860
DOI: 10.1038/s41564-022-01170-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamstersPMID 35705860Read ↗

Current status of therapeutic monoclonal antibodies against SARS-CoV-2.Semantic proximity Read ↗

ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infectionSemantic proximity Read ↗

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection.Semantic proximity Read ↗

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Semantic proximity Read ↗

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsSemantic proximity Read ↗

Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variantSemantic proximity Read ↗

Pathogenicity of SARS-CoV-2 Omicron BA.5 and BE.1 Variants in Syrian Hamsters and hACE2-transgenic MmiceSemantic proximity Read ↗

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.Semantic proximity Read ↗

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 modelSemantic proximity Read ↗

Activity of Tixagevimab/Cilgavimab against the Omicron variant of SARS-CoV-2 in a hamster modelSemantic proximity Read ↗

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing StrategySemantic proximity Read ↗

Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.